CEO out at Durham's Chimerix soon after public outcry over experimental drug

April 10, 2014 1:33 PM

18 0

CEO out at Durham's Chimerix soon after public outcry over experimental drug

A month after making national headlines for withholding an experimental drug from a critically ill child, Kenneth Moch is out as CEO of Durham drug maker Chimerix.

In the unexpected decision Wednesday, Chimerix named M. Michelle Berrey as chief executive officer, immediately succeeding Moch.

Read more

To category page

Loading...